Triage performance of PAX1m/JAM3m in opportunistic cervical cancer screening of non‒16/18 human papillomavirus-positive women: a multicenter prospective study in China
Xiaojing Chen & Lei Li et al. · 2024-08-16
In this study, we aimed to validate the performance of the PAX1 and JAM3 methylation (PAX1 The triage performance of liquid-based cytology (LBC) and the PAX1 In total, 1851 participants had cervical histological outcomes and were included in the analysis. The sensitivity/specificity of the LBC test results with atypical squamous cells of undetermined significance or worse (LBC ≥ ASCUS) and the PAX1 In non-16/18 hrHPV(+) women, PAX1